(Q41730079)

English

Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection

scientific article published on February 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

1 reference

Europe PubMed Central

Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

author name string

Welliver RC

1

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

publication date

1 February 1998

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Seminars in Perinatology

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

87-95

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Respiratory syncytial virus infection: admissions to hospital in industrial, urban, and rural areas. Report to the Medical Research Council Subcommittee on Respiratory Syncytial Virus Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Testing models predicting severity of respiratory syncytial virus infection on the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Neonatal respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent outbreaks of rhinovirus and respiratory syncytial virus in an intensive care nursery: Epidemiology and associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980010-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0146-0005(98)80010-4

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41730079&oldid=1926644535"